Literature DB >> 35734364

Serum Bile Acids in Intrahepatic Cholestasis of Pregnancy (ICP), Versus Pregnant and Nonpregnant Controls in Asian Indian Women and a Proposed Scoring to Optimize Management in ICP.

Nutan Agarwal1, Reeta Mahey1, Vidushi Kulshrestha1, Alka Kriplani1, Anoop Saraya1, Vikas Sachdev1.   

Abstract

Objectives: This prospective clinical trial was conducted to assess serum bile acids (BA) levels in women with intrahepatic cholestasis of pregnancy (ICP) compared to both pregnant and non-pregnant controls; and evaluate perinatal outcome in relation to bile acid levels. A scoring is proposed based on biochemical markers to optimize management in ICP cases. Materials and
Methods: Serum bile-acids(BA) were assessed in 71 intrahepatic-cholestasis of pregnancy(ICP) cases (group-I), versus 50 pregnant (group-II) and 35 non-pregnant (group-III) controls. Ursodeoxycholic acid (UDCA) was administered in ICP group. Baseline bilirubin (SB), aminotransferases (AT), alkaline-phosphatase were sent in groups I & II. Investigations were repeated in group-I after 4 weeks. Perinatal complications were noted.
Results: Mean BA in group-I was 75.92 ± 39.9 µmol/L which reduced to 41.3 ± 15.4 µmol/L(45.6%, p < 0.001) with UDCA. Mean BA was 29.2 ± 5.7 and 5.9 ± 1.8 µmol/L in group-II and group-III. UDCA significantly reduced itching-score. Rate of fetal distress linearly increased with the increasing baseline levels of serum BA, AT and SB: from 2.5 to 100% at BA < 40 and ≥ 200 µmol/L, (p = 0.008); from 16.1 to 100% at AT < 100 and ≥ 500 IU/mL(p = 0.016); and from 6.8 to 100% at SB < 0.8 and > 5 mg/dL (p = 0.001); respectively. Their baseline levels were divided into 5 groups in correlation to fetal distress. Serum BA < 40, 40-80, 80-120, 120-200, ≥ 200 µmol/L; AT < 100,100-200,200-500, ≥ 500 IU/mL; and SB < 0.8, 0.8-1.0, 1.1-2, 2.1-5 and > 5 mg/dL. Nutan ICP scoring was proposed with a score 0 to 4 given to each parameter and score-based management protocol was suggested for fetal surveillance and delivery. Conclusions: SBA are higher in Asian Indian pregnant women. Levels > 30 µmol/L can be taken as a cut off for diagnosing ICP in Asian-Indian women. Adopting higher cut-offs for this geographic part will avoid over-diagnosing ICP and iatrogenic early termination of pregnancy. Suggested scoring will help clinicians in optimizing the time of delivery on an individualized basis. © Federation of Obstetric & Gynecological Societies of India 2021.

Entities:  

Keywords:  Intrahepatic cholestasis of pregnancy; Scoring for ICP; Serum bile acid; Ursodeoxycholic acid

Year:  2021        PMID: 35734364      PMCID: PMC9206981          DOI: 10.1007/s13224-021-01501-1

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  24 in total

1.  Obstetric Outcome During an Era of Active Management for Obstetrics Cholestasis.

Authors:  Nalini Sharma; S Panda; Ahanthem Santa Singh
Journal:  J Obstet Gynaecol India       Date:  2015-09-08

2.  Pruritus in pregnancy: a study of anatomical distribution and prevalence in relation to the development of obstetric cholestasis.

Authors:  A P Kenyon; R M Tribe; C Nelson-Piercy; J C Girling; C Williamson; P T Seed; S Vaughan-Jones; A H Shennan
Journal:  Obstet Med       Date:  2010-03-04

3.  The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestational age.

Authors:  Anela Puljic; Elissa Kim; Jessica Page; Tania Esakoff; Brian Shaffer; Daphne Y LaCoursiere; Aaron B Caughey
Journal:  Am J Obstet Gynecol       Date:  2015-02-14       Impact factor: 8.661

4.  The effects of ursodeoxycholic acid treatment for intrahepatic cholestasis of pregnancy on maternal and fetal outcomes: a meta-analysis including non-randomized studies.

Authors:  Sophie Grand'Maison; Madeleine Durand; Michèle Mahone
Journal:  J Obstet Gynaecol Can       Date:  2014-07

5.  Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels.

Authors:  Laura Brouwers; Maria P H Koster; Godelieve C M L Page-Christiaens; Hans Kemperman; Janine Boon; Inge M Evers; Auke Bogte; Martijn A Oudijk
Journal:  Am J Obstet Gynecol       Date:  2014-07-18       Impact factor: 8.661

Review 6.  Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis.

Authors:  Yannick Bacq; Loïc Sentilhes; Humberto B Reyes; Anna Glantz; Jurate Kondrackiene; Tomas Binder; Pier Luigi Nicastri; Anna Locatelli; Annarosa Floreani; Ismael Hernandez; Vincent Di Martino
Journal:  Gastroenterology       Date:  2012-08-11       Impact factor: 22.682

7.  Perinatal death by bile acid levels in intrahepatic cholestasis of pregnancy: a systematic review.

Authors:  Daniele Di Mascio; Johanna Quist-Nelson; Melissa Riegel; Brandon George; Gabriele Saccone; Romana Brun; Christian Haslinger; Christina Herrera; Tetsuya Kawakita; Richard H Lee; Pierluigi Benedetti Panici; Vincenzo Berghella
Journal:  J Matern Fetal Neonatal Med       Date:  2019-11-19

Review 8.  Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).

Authors:  Xiang Kong; Yan Kong; Fangyuan Zhang; Tingting Wang; Jin Yan
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

9.  Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.

Authors:  Caroline Ovadia; Paul T Seed; Alexandros Sklavounos; Victoria Geenes; Chiara Di Ilio; Jenny Chambers; Katherine Kohari; Yannick Bacq; Nuray Bozkurt; Romana Brun-Furrer; Laura Bull; Maria C Estiú; Monika Grymowicz; Berrin Gunaydin; William M Hague; Christian Haslinger; Yayi Hu; Tetsuya Kawakita; Ayse G Kebapcilar; Levent Kebapcilar; Jūratė Kondrackienė; Maria P H Koster; Aneta Kowalska-Kańka; Limas Kupčinskas; Richard H Lee; Anna Locatelli; Rocio I R Macias; Hanns-Ulrich Marschall; Martijn A Oudijk; Yael Raz; Eli Rimon; Dan Shan; Yong Shao; Rachel Tribe; Valeria Tripodi; Cigdem Yayla Abide; Ilter Yenidede; Jim G Thornton; Lucy C Chappell; Catherine Williamson
Journal:  Lancet       Date:  2019-02-14       Impact factor: 202.731

Review 10.  Intrahepatic Cholestasis in Pregnancy: Review of the Literature.

Authors:  Joanna Piechota; Wojciech Jelski
Journal:  J Clin Med       Date:  2020-05-06       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.